Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117342 | SCV000151524 | benign | not specified | 2013-03-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117342 | SCV000169972 | benign | not specified | 2013-01-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000117342 | SCV000202885 | benign | not specified | 2014-04-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000227658 | SCV000291570 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000117342 | SCV000316427 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002312147 | SCV000846608 | benign | Inborn genetic diseases | 2016-05-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |